These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39223828)

  • 1. BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple-negative breast cancer (TNBC) cells.
    Rossi T; Iorio E; Chirico M; Pisanu ME; Amodio N; Cantafio MEG; Perrotta I; Colciaghi F; Fiorillo M; Gianferrari A; Puccio N; Neri A; Ciarrocchi A; Pistoni M
    Cell Prolif; 2024 Dec; 57(12):e13730. PubMed ID: 39223828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Dual CDK6/BRD4 Inhibitor Inducing Apoptosis and Increasing the Sensitivity of Ferroptosis in Triple-Negative Breast Cancer.
    Zhang Y; Zheng L; Ma L; Yin F; Luo Z; Li S; Jiang Y; Kong L; Wang X
    J Med Chem; 2024 Dec; 67(23):21186-21207. PubMed ID: 39575863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromodomain inhibitor treatment leads to overexpression of multiple kinases in cancer cells.
    Chandrashekar DS; Afaq F; Karthikeyan SK; Athar M; Shrestha S; Singh R; Manne U; Varambally S
    Neoplasia; 2024 Nov; 57():101046. PubMed ID: 39241280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potent Bioorganic azapodophyllotoxin derivative Suppresses tumor Progression in Triple negative breast Cancer: An Insight into its Inhibitory effect on tubulin polymerization and Disruptive effect on microtubule assembly.
    Gupta S; Dev J R A; Prakash Prasad C; Kumar A; Kumar Ghosh S
    Bioorg Chem; 2024 Dec; 153():107839. PubMed ID: 39326339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of 4-aminophenol-1,3,4-oxadiazole derivative potentiates apoptosis by targeting MAP kinase in triple negative breast cancer cells.
    Dhanalakshmi B; Anil Kumar BM; Muddenahalli Srinivasa S; Vivek HK; Sennappan M; Rangappa S; Srinivasa Murthy V
    J Biomol Struct Dyn; 2024; 42(23):13114-13129. PubMed ID: 37948299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitors.
    Ding X; Liang J; Sharko AC; Hilimire TA; Li J; Loskutov J; Mack ZT; Ji H; Schools GP; Cai C; Pugacheva EN; Chen M; Roninson IB; Broude EV
    Proc Natl Acad Sci U S A; 2024 Nov; 121(47):e2414501121. PubMed ID: 39541354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytosesquiterpene lactones deregulate mitochondrial activity and phenotypes associated with triple-negative breast cancer metastasis.
    Cheng YT; Chang DM; Tung YC; Hsiao PW; Nakagawa-Goto K; Shyur LF
    Phytomedicine; 2024 Dec; 135():156226. PubMed ID: 39571415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabidiol Enhances Atezolizumab Efficacy by Upregulating PD-L1 Expression via the cGAS-STING Pathway in Triple-Negative Breast Cancer Cells.
    Kim BG; Kim BR; Kim DY; Kim WY; Kang S; Lee SI; Oh SC
    Cancer Immunol Res; 2024 Dec; 12(12):1796-1807. PubMed ID: 39226389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic Anti-Tumor Effects of Newcastle Disease Virus and Doxorubicin: Evidence from A Murine Breast Cancer Model.
    Sabri H; Barough MS; Zafari E; Pakjoo M; Mahdavi M; Esmaeili F; Sadeghi S; Sarrami-Forooshani R
    Int Immunopharmacol; 2024 Dec; 143(Pt 2):113481. PubMed ID: 39467343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cells.
    Pellegrino B; David K; Rabani S; Lampert B; Tran T; Doherty E; Piecychna M; Meza-Romero R; Leng L; Hershkovitz D; Vandenbark AA; Bucala R; Becker-Herman S; Shachar I
    PLoS Biol; 2024 Nov; 22(11):e3002905. PubMed ID: 39576827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLIS3: A novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease.
    Collier JB; Kang HS; Roh YG; Srivastava C; Grimm SA; Jarmusch AK; Jetten AM
    Mol Metab; 2024 Dec; 90():102052. PubMed ID: 39505148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the γ-secretase/NICD-PXR/Notch pathway induces Taxol resistance in triple-negative breast cancer.
    Wang ZJ; Zhan XY; Ma LY; Yao K; Dai HY; Kumar Santhanam R; Zhou MS; Jia H
    Biochem Pharmacol; 2024 Dec; 230(Pt 2):116577. PubMed ID: 39427919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I.
    Stephenson ZA; Harvey RF; Pryde KR; Mistry S; Hardy RE; Serreli R; Chung I; Allen TE; Stoneley M; MacFarlane M; Fischer PM; Hirst J; Kellam B; Willis AE
    Elife; 2020 May; 9():. PubMed ID: 32432547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib.
    Jonas K; Prinz F; Ferracin M; Krajina K; Pasculli B; Deutsch A; Madl T; Rinner B; Slaby O; Klec C; Pichler M
    Breast Cancer Res; 2023 Oct; 25(1):119. PubMed ID: 37803350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of bromo-naphthoquinone associated with tannic acid in triple negative breast cancer cells.
    Carvalho EP; Pessoa AS; Iano FG; Ribeiro L; Leme B; Borges LF; Sanches MLR; Ximenes VF; Oliveira RC
    Int J Biochem Cell Biol; 2024 Dec; 177():106697. PubMed ID: 39566654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMAL1 and CLOCK proteins exhibit differential association with mitochondrial dynamics, protein synthesis pathways and muscle strength in human muscle.
    Figueroa-Toledo AM; Gutiérrez-Pino J; Carriel-Nesvara A; Marchese-Bittencourt M; Zbinden-Foncea H; Castro-Sepúlveda M
    J Physiol; 2024 Dec; 602(23):6403-6415. PubMed ID: 38922907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-Like receptor 3-mediated interferon-β production is suppressed by oncostatin m and a broader epithelial-mesenchymal transition program.
    Chernosky NM; Tamagno I; Polak KL; Chan ER; Yuan X; Jackson MW
    Breast Cancer Res; 2024 Nov; 26(1):167. PubMed ID: 39593161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Mechanism of Ferroptosis Induction by Sappanone A in Cancer: Insights into the Mitochondrial Dysfunction Mediated by NRF2/xCT/GPX4 Axis.
    Wang J; Zhuang H; Yang X; Guo Z; Zhou K; Liu N; An Y; Chen Y; Zhang Z; Wang M; Chen J; Li C; Chang X
    Int J Biol Sci; 2024; 20(13):5145-5161. PubMed ID: 39430236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative phosphorylation decline and mitochondrial dynamics disequilibrium are involved in chicken large white follicle atresia.
    Hu J; Li J; Zheng S; Chen Y; Zhang Y; Deng J; Fan J; Xu H; Lu Y; Liu X
    Theriogenology; 2025 Jan; 232():87-95. PubMed ID: 39520960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icariin promoted ferroptosis by activating mitochondrial dysfunction to inhibit colorectal cancer and synergistically enhanced the efficacy of PD-1 inhibitors.
    Haoyue W; Kexiang S; Shan TW; Jiamin G; Luyun Y; Junkai W; Wanli D
    Phytomedicine; 2024 Nov; 136():156224. PubMed ID: 39642461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.